|
KMID : 1188320140080030265
|
|
Gut and Liver
2014 Volume.8 No. 3 p.265 ~ p.270
|
|
|
Acute Pancreatitis Secondary to Ciprofloxacin Therapy in Patients with Infectious Colitis
|
|
Sung Hye-Young
Kim Jin-Il
Lee Hyun-Jeong
Cho Hyung-Jun
Cheung Dae-Young
Kim Sung-Soo
Cho Se-Hyun
Kim Jae-Kwang
|
|
|
Abstract
|
|
|
Background/Aims:Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis. However, this drug may cause drug-induced pancreatitis, albeit rarely.
Methods:From March 2007 to February 2012, we studied 227 patients who were hospitalized for infectious colitis at St. Mary's Hospital. All of the patients received ciprofloxacin therapy for the treatment of infectious colitis. We observed a few cases of rare adverse events, including ciprofloxacin-induced acute pancreatitis diagnosed based on the Naranjo algorithm.
Results:During ciprofloxacin therapy, seven of 227 patients (3.1%) developed rare pancreatitis as defined by the Naranjo algorithm; pancreatic enzyme activity was sporadically elevated with ciprofloxacin use. After ciprofloxacin administration, the average interval until the development of pancreatitis was 5.5 days (range, 4 to 7 days). On abdominal computed tomography, pancreatic swelling and homogenous enhancement was noted in three of seven patients. Complicating acute pancreatitis was gradually but completely resolved after cessation of ciprofloxacin administration. The mean recovery time was 11.3 days (range, 8 to 15 days).
Conclusions:We observed that ciprofloxacin-induced pancreatitis may occur with an incidence of approximately 3%. Ciprofloxacin-induced pancreatitis presents a short latency, suggesting an idiosyncratic hypersensitivity reaction. Practitioners should be aware that drug-induced pancreatitis can occur during ciprofloxacin therapy.
|
|
|
KEYWORD
|
|
|
Anti-bacterial agents, Pancreatitis, Drug toxicity, Infectious colitis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|
|